A Prospective Randomised Phase III Study of Androgen Deprivation Therapy (+/- Docetaxel) With or Without Local Radiotherapy With or Without Abiraterone Acetate and Prednisone in Patient With Metastatic Hormone-naïve Prostate Cancer
Phase of Trial: Phase III
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Abiraterone acetate (Primary) ; LHRH receptor agonists; LHRH receptor antagonists; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms GETUG AFU 21; PEACE1
- 10 Jun 2017 Biomarkers information updated
- 28 Jun 2016 Docetaxel drug is added hence Study Title has been changed.
- 28 Jun 2016 Planned primary completion date changed from 1 Oct 2016 to 1 May 2017.